Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
REGULUS THERAP (NQ: RGLS)
7.050 USD  +0.050 (+0.71%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News
All news about REGULUS THERAP
 
Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
May 21, 2013
from PR Newswire
Investors Begin To Realize RNA’s Potential
May 21, 2013
from ACCESSWIRE
Regulus Therapeutics (NASDAQ: RGLS) Clinical Candidate in HCV Nominated; Reiterate Buy - Needham & Company
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8339421 for the full story. Read More
from StreetInsider.com News Articles
Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
May 14, 2013
- Nominated RG-101 in HCV as First microRNA Candidate for Clinical Development- Read More
from PR Newswire
Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
May 07, 2013
from PR Newswire
Regulus to Present at 12th Annual Needham Healthcare Conference
April 24, 2013
from PR Newswire
Zosano Pharma, Inc. Expands Board of Directors with Addition of Kleanthis G. Xanthopoulos, Ph.D.
April 15, 2013
from PR Newswire
Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
April 01, 2013
Industry Legend Brings Deep Biotechnology Expertise Read More
from PR Newswire
Regulus to Present at Future Leaders in the Biotech Industry Conference
March 28, 2013
from PR Newswire
Top Gainers: ITT Educational Services, Panasonic Corporation, Regulus Therapeutics Inc, Books-A-Million
March 28, 2013
Lakeway, TX -- (SBWIRE) -- 03/28/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
February 26, 2013
from PR Newswire
NASDAQ Top Percentage Gainers; (MNOV), (ACFC), (RGLS), (GBLI)
February 26, 2013
New York, New York - February 26, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors... Read More
category NASDAQ:ACFC , NASDAQ:MNOV , NASDAQ:GBLI , and 1 more.
from Investorideas.com newswire, stock news and business news for investors
Regulus Therap (RGLS) Reports Q4 Loss of 22c
February 20, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8117535 for the full story. Read More
from StreetInsider.com News Articles
Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
February 20, 2013
-Progressed Partnered and Proprietary microRNA Programs- Read More
from PR Newswire
Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
February 13, 2013
from PR Newswire
Regulus to Present at Two Upcoming Investor Conferences
February 04, 2013
from PR Newswire
Regulus Appoints Mark G. Foletta to its Board of Directors
January 31, 2013
Mr. Foletta Brings Extensive Financial and Commercial Biotechnology Expertise Read More
from PR Newswire
Regulus to Present at 31st Annual J.P. Morgan Healthcare Conference
January 03, 2013
from PR Newswire
The Real Story Behind STAA, ALC, RGLS and ONCY
January 02, 2013
from Marketwired News Releases
Stocks Hitting 52-Week Highs
December 28, 2012
Provident Financial Holdings (NASDAQ: PROV ) shares gained 2.71% to create a new 52-week high of $17.45. Provident Financial's trailing-twelve-month operating margin is 33.26%. Ambarella (NASDAQ: AMBA... Read More
category US16938C1062 , Benzinga , RGLS , and 9 more.
from Latest Articles from Benzinga.com
Regulus Therapeutics Inc. (NASDAQ:RGLS), Southcoast Financial Corp. (NASDAQ:SOCB), PokerTek, Inc. (NASDAQ:PTEK) and Deckers Outdoor Corp. (NASDAQ:DECK) Have Been Added to Growing Stock Report's NASDAQ
December 27, 2012
New York, NY -- (SBWIRE) -- 12/27/2012 -- Growing Stock Report iniates a NASDAQ Percentage Gainer Watch List and Investor Poll for the following stocks: Regulus Therapeutics Inc. (NASDAQ:RGLS),... Read More
from SBWire - Latest Press Releases
Regulus Announces Addition to Russell 2000 Index
December 20, 2012
from PR Newswire
Video Interview: Kleanthis G. Xanthopoulos, Ph.D., President and Chief Executive Officer, Regulus Therapeutics Inc. [RGLS]
December 07, 2012
NASDAQ CEO Signature Series Broadcasted From the NASDAQ MarketSite Read More
from GlobeNewswire News Releases
Regulus Therapeutics Inc. [RGLS] to Ring The NASDAQ Stock Market Closing Bell
December 04, 2012
Event is Part of Regulus Therapeutics Inc's Launch as a Public Company Read More
from GlobeNewswire News Releases
Regulus to Host NASDAQ Closing Bell Ceremony on December 5, 2012
December 03, 2012
from PR Newswire
Organizations Record Getting in the HEALTHCARE Sector (CLVS, RGDX, RGLS, ALIM)
November 30, 2012
New York, NY -- (SBWIRE) -- 11/30/2012 -- PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We... Read More
from SBWire - Latest Press Releases
UPDATE: Wedbush Securities Initiates Regulus Therapeutics at Outperform on Pipeline Progress
November 29, 2012
Wedbush Securities initiated coverage on Regulus Therapeutics (NASDAQ: RGLS ) with an Outperform rating and a $10 price target. Wedbush Securities noted, "Regulus is developing oligonucleotide drugs... Read More
category Wedbush Securities , Benzinga , RGLS , and 4 more.
from Latest Articles from Benzinga.com
Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
November 27, 2012
from PR Newswire
Regulus Therap (RGLS) Reports Q3 Loss of $15.98
November 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7891633 for the full story. Read More
from StreetInsider.com News Articles
Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
November 19, 2012
-Formed Multiple Strategic Relationships to Support our microRNA-based Therapeutics and Biomarker Platforms- Read More
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here